Chemoinformaics analysis of Dihydrocuminaldehyde
Molecular Weight | 150.221 | nRot | 2 |
Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
Exact Molecular Weight | 150.104 | nRing | 1 |
Solubility: LogS | -1.867 | nHRing | 0 |
Solubility: LogP | 1.707 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 26.8371 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.525 |
Synth | 4.225 |
Natural Product Likeliness | 1.94 |
NR-PPAR-gamma | 0.874 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.006 |
HIA | 0.01 |
CACO-2 | -4.51 |
MDCK | 0.0000235 |
BBB | 0.922 |
PPB | 0.521342 |
VDSS | 2.73 |
FU | 0.567055 |
CYP1A2-inh | 0.094 |
CYP1A2-sub | 0.22 |
CYP2c19-inh | 0.039 |
CYP2c19-sub | 0.809 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.124 |
CYP2d6-inh | 0.058 |
CYP2d6-sub | 0.469 |
CYP3a4-inh | 0.109 |
CYP3a4-sub | 0.545 |
CL | 9.187 |
T12 | 0.843 |
hERG | 0.021 |
Ames | 0.146 |
ROA | 0.086 |
SkinSen | 0.963 |
Carcinogencity | 0.84 |
EI | 0.925 |
Respiratory | 0.814 |
NR-Aromatase | 0.294 |
Antiviral | No |
Prediction | 0.942663 |